Elizabeth C Smyth1, Russell D Petty2. Show Affiliations » 1. Royal Marsden Hospital, London SW3 6JJ, UK. Electronic address: elizabeth.smyth2@nhs.net. 2. Ninewells Hospital and School of Medicine, University of Dundee, Dundee, UK.
Abstract
Entities: Chemical Disease
Mesh： See more » Adenocarcinoma/drug therapyAdenocarcinoma/mortalityAdenocarcinoma/pathologyAgedAntibodies, Monoclonal, Humanized/adverse effectsAntibodies, Monoclonal, Humanized/therapeutic useAntineoplastic Combined Chemotherapy Protocols/adverse effectsAntineoplastic Combined Chemotherapy Protocols/therapeutic useDisease-Free SurvivalEsophageal Neoplasms/drug therapyEsophageal Neoplasms/mortalityEsophageal Neoplasms/pathologyEsophagogastric Junction/pathologyFemaleFollow-Up StudiesHumansImmunotherapyInfusions, IntravenousMaleMiddle AgedNeoplasm StagingPaclitaxel/adverse effectsPaclitaxel/therapeutic useStomach Neoplasms/drug therapyStomach Neoplasms/pathologyTreatment Outcome
Substances： See more » Antibodies, Monoclonal, HumanizedpembrolizumabPaclitaxel
Year: 2018 PMID： 29880232 DOI： 10.1016/S0140-6736(18)31277-7
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321